WCN26-4529 Pathophysiological characterization of sarcopenia associated with chronic kidney disease using metabolomics

Read full text Summarise with VIRAT
Authors: A. Hara, Daisuke Saigusa, Seiko Yamakoshi, Nobuyuki Takahashi, Emiko Sato
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Sarcopenia is characterized by the progressive loss of skeletal muscle mass and strength with aging. In patients with chronic kidney disease (CKD), sarcopenia frequently coexists and worsens physical frailty and mortality, especially among the elderly. However, preventive or therapeutic strategies for CKD-associated sarcopenia remain undefined. We have previously reported that uremic toxins accumulate not only in the circulation but also within skeletal muscle, contributing to muscle wasting. Yet, the detailed metabolic alterations underlying CKD-associated sarcopenia remain unclear.

Fields of Study & Subjects

Nutrition and Health in Aging Dialysis and Renal Disease Management Muscle Physiology and Disorders

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
104990–104990
Publication date
25 March 2026
Language
EN